Find your next quality investment with Simply Wall St's easy and powerful screener, trusted by over 7 million individual investors worldwide.

Crane (CR) just delivered first quarter 2026 results that topped Wall Street expectations on revenue and adjusted profit. However, the stock slipped as investors focused on a weaker operating margin and a cautious reaction to guidance.

See our latest analysis for Crane.

At a share price of $181.61, Crane has a 30 day share price return of 5.14%, while the year to date share price return is slightly negative and the 5 year total shareholder return of 216% points to strong longer term compounding, with recent earnings, acquisition updates and a reaffirmed dividend all feeding into shifting sentiment around growth and risk.

If Crane's results have you thinking about where else industrial demand and infrastructure investment could matter, it may be worth scanning 34 power grid technology and infrastructure stocks

With revenue and adjusted profit ahead of expectations, a modest intrinsic discount and a history of strong multi year returns, the real question now is whether Crane is still on sale or if the stock already reflects future growth.

Most Popular Narrative: 17.3% Undervalued

Crane's most followed narrative pegs fair value at about $219.67 versus the recent $181.61 share price. This sets up a valuation built around acquisitions, earnings power and cash flows discounted at 8.78%.

Crane's recent acquisition of PSI (Druck, Panametrics, Reuter-Stokes) positions the company to capture rising demand for advanced sensing and fluid control in both aerospace and process industries, directly benefiting from infrastructure modernization and growing automation supporting sustained revenue and future margin expansion.

Read the complete narrative.

Want to see what is baked into that fair value gap? The narrative leans heavily on compounding revenue, rising margins and a richer future earnings multiple. It explores which assumptions really move the model.

Result: Fair Value of $219.67 (UNDERVALUED)

Have a read of the narrative in full and understand what's behind the forecasts.

However, this hinges on healthy end markets and clean integration, since weaker European chemical demand or acquisition missteps could quickly challenge those fair value assumptions.

Find out about the key risks to this Crane narrative.

Another View on Valuation

The popular narrative leans on discounted cash flow to argue Crane is undervalued. Yet the current 32.7x P/E is higher than both the US Machinery industry at 27.4x and the peer average of 31.1x, and it also sits above a fair ratio of 26.9x. That kind of premium can signal optimism, but it may also limit the potential upside if sentiment cools.